H4: the lot was manufactured between august 18, 2023- august 21, 2023.H10: the actual device was received for evaluation containing drug fluid in the bladder.Visual inspection identified several small white specks of drug powder located on the outer surface of the device.A functional leak test was performed by adding green color water to the bladder.The device was being monitored until the next day and no evidence of leak was observed.The reported condition was verified.The cause of the condition could not be determined; however, the most probable cause was due to user error.During the filling step, drops of drug fluid may have inadvertently dropped onto the outer surface of the device bottle and overtime, the drug fluid dried up into powder form.The drug powder came from the drug fluid, not from the folfusor device.The device was determined to be a conforming product.A batch review was conducted and there were no deviations found related to this reported condition during the manufacture of this lot.Should additional relevant information become available, a supplemental report will be submitted.
|